Novo Nordisk Inc Drug Patent Portfolio

Novo Nordisk Inc's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

With the expiration of the Ozempic patent in India, health experts warn about potential negative impacts. Who stands to lose the most?

29 Mar, 2026

As GLP-1 medications gain popularity, the patent for Ozempic lapses in India; health professionals caution about potential impacts.

29 Mar, 2026

On the topic of generic medications and quality standards... - Metro India

28 Mar, 2026

Novo Nordisk takes legal action against Dr. Reddy's in India over trademark dispute involving Ozempic and Olymviq.

27 Mar, 2026